Stock Comparison

ABBV vs HITI

AbbVie Inc vs High Tide Inc

The Verdict

HITI takes this one.

ABBV

AbbVie Inc

0.1

out of 10

Distressed

Winner

HITI

High Tide Inc

7.5

out of 10

Solid Pick

Head-to-Head

$403.8B

Market Cap

$297M

171.8

P/E Ratio

-6.8

N/A

Profit Margin

-7.4%

N/A

Return on Equity

-40.9%

N/A

Debt-to-Equity

1.3

Moderate

Overall Risk

Aggressive

0.1

DVR Score

7.5

The Deep Dive

ABBV0.1/10

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Full ABBV Analysis

HITI7.5/10

Score Change Explanation: The previous analysis on 2026-04-10 assigned a score of 8.4/10 based on robust Q1 fiscal 2026 results, highlighting strong revenue growth, Adjusted EBITDA, and positive free cash flow. However, the most recent Q2 fiscal 2026 earnings (reported March 17, 2026) revealed a material deterioration. Revenue of $130.88 million significantly missed consensus estimates of $173.80 ...

Full HITI Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.